市场调查报告书
商品编码
1558342
2030 年维生素 B12 市场预测:按产品类型、形式、等级、销售管道、应用、最终用户和地区进行的全球分析Vitamin B12 Market Forecasts to 2030 - Global Analysis By Product Type (Cyanocobalamin, Hydroxocobalamin, Methylcobalamin and Adenosylcobalamin), Form, Grade, Sales Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球维生素 B12 市场规模为 2.113 亿美元,预计到 2030 年将达到 3.506 亿美元,预测期内复合年增长率为 8.8%。
维生素 B12,也称为钴胺素,是一种水溶性维生素,在多种身体功能中发挥重要作用。对于红血球的形成、神经系统的维护和 DNA 合成至关重要。维生素B12在维生素中是独一无二的,因为它含有矿物质钴,其化合物统称为钴胺素,其中包括甲基钴胺素和5-脱氧腺苷钴胺素等活性形式,以及羟钴胺素和氰钴胺素等体内活性形式,也有惰性形式。因此,透过饮食和补充品摄取足够的营养极为重要,尤其是对于高风险族群。
根据2022年3月发表在《人类营养与代谢》的论文,第二型糖尿病等慢性疾病患者维生素B12缺乏的盛行率为17.5%。
维生素 B12 缺乏症盛行率上升
随着人们越来越认识到维生素 B12 缺乏症对健康的影响,越来越多的人正在寻求补充品来预防或控制维生素 B12 缺乏症。对于老年人、素食者和患有抑制营养吸收的胃肠道疾病的人等高风险族群尤其如此。医疗保健专业人士越来越多地推荐维生素 B12补充品作为标准治疗通讯协定的一部分,进一步刺激了市场需求。
有限的自然资源
人们越来越依赖维生素 B12 强化食品和补充品,这是由于天然来源有限,导致市场波动,并且在可靠选择较少的地区可能会受到限制。此外,维生素 B12补充品和强化食品製造商之间的竞争会增加行销成本并产生价格压力,从而阻碍市场成长,从而影响消费者信心和市场稳定。
素食者和素食者的增加
由于越来越多的素食主义者和素食者采用植物性饮食,对维生素 B12补充品的需求不断增加。这些饮食具有很高的缺乏症风险,增加了对营养食品的需求。食品製造商正在扩大植物奶、谷物和营养酵母等强化食品的生产,以满足该族群的营养需求,从而促进市场成长。
开发中国家认知度低
对维生素 B12 缺乏症的认识有限可能会导致病例报告不足和公共卫生工作不足,从而阻碍市场成长。因此,公司不愿意投资于针对这一人群的行销和产品开拓。此外,政府未能优先考虑微量营养素缺乏症可能会导致卫生政策不足、缺乏食品强化工作和教育宣传活动,并进一步阻碍维生素 B12 产品的市场成长机会。
COVID-19 大流行对维生素 B12 市场产生了重大影响,随着消费者专注于提高免疫力,导致对补充品的需求增加。健康专家和组织强调了维生素(包括 B12)在这场危机期间维持整体健康的重要性。这种意识的提高正在推动维生素 B12 产品的销售,预计未来几年将持续成长。
氰钴胺部分预计将在预测期内成为最大的部分
氰钴胺预计在预测期内增长最快,因为它被认为是维生素 B12 最稳定的形式,这有助于其在市场上的主导地位。由于其稳定性,与其他形式的维生素 B12(例如甲钴胺和腺苷钴胺)相比,它更容易处理并且保质期更长。这种稳定性使得氰钴胺的生产、储存和运输劣化风险较小,因其稳定的供应和可用性而成为製造商的首选。
营养食品产业预计在预测期内复合年增长率最高
由于缺乏维生素 B12补充品的需求激增,食品产业预计在预测期内将出现最高的复合年增长率。补充品传递技术的进步,例如舌下片剂、粉末和经皮吸收贴片,使消费者更容易将维生素 B12 融入日常生活中。
由于营养食品的使用不断增加、以预防医学为重点的医疗保健行业的进步以及该地区可用的产品种类繁多,北美在预测期内占据了最大的市场占有率。此外,神经系统和胃肠道疾病的日益普及导致该地区钴胺素补充品的消费量增加。
亚太地区在预测期内将出现最高的复合年增长率,因为糖尿病神经病变的高患病率、人口老龄化的加剧以及保健补充品意识的提高预计将成为推动该地区增长的因素。此外,预计主要企业的存在和产能的扩大将在预计几年内对该地区的市场成长做出重大贡献。
According to Stratistics MRC, the Global Vitamin B12 Market is accounted for $211.3 million in 2024 and is expected to reach $350.6 million by 2030 growing at a CAGR of 8.8% during the forecast period. Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a crucial role in various bodily functions. It is essential for the formation of red blood cells, maintenance of the nervous system, and DNA synthesis. Vitamin B12 is unique among vitamins because it contains the mineral cobalt, and its compounds are collectively referred to as cobalamins, which include active forms like methylcobalamin and 5-deoxyadenosylcobalamin, as well as inactive forms such as hydroxycobalamin and cyanocobalamin that convert into active forms in the body. Thus adequate intake through diet or supplementation is crucial, especially for at-risk populations.
According to the article published in Human Nutrition & Metabolism in March 2022, the prevalence of B12 deficiency in patients with chronic diseases such as type 2 diabetes was 17.5%.
Rising prevalence of vitamin B12 deficiency
As awareness of the health implications of vitamin B12 deficiency grows, more individuals are seeking supplements to prevent or address deficiencies. This is particularly true among at-risk populations, including the elderly, vegetarians, and those with gastrointestinal disorders that impair nutrient absorption. Healthcare professionals are increasingly recommending vitamin B12 supplements as part of standard treatment protocols, further boosting market demand
Limited natural sources
The growing dependency on fortified foods and supplements for vitamin B12 is due to limited natural sources, leading to market fluctuations and potential limitations in regions with less trusted options. Additionally, competition among manufacturers of vitamin B12 supplements and fortified foods creates increased marketing costs and pricing pressures, potentially affecting consumer trust and market stability hampering the market growth.
Increase in vegan and vegetarian populations
The demand for vitamin B12 supplements is increasing due to the increasing number of vegans and vegetarians adopting plant-based diets. These diets are at a higher risk of deficiency, leading to a need for dietary supplements. Food manufacturers are expanding fortified food products, such as plant-based milks, cereals, and nutritional yeast, to meet the nutritional needs of these populations, contributing to market growth.
Limited awareness in developing countries
Limited awareness about vitamin B12 deficiency can lead to underreporting of cases, causing insufficient public health initiatives and hindering market growth. This can result in companies hesitant to invest in marketing or product development for these populations. Additionally, inadequate health policies can result from governments not prioritizing micronutrient deficiencies, leading to a lack of food fortification initiatives and educational campaigns, further stunting market growth opportunities for vitamin B12 products.
The COVID-19 pandemic has significantly impacted the vitamin B12 market, leading to increased demand for supplements as consumers focus on boosting their immunity. Health experts and organizations have emphasized the importance of vitamins, including B12, in maintaining overall health during the crisis. This heightened awareness has driven sales of vitamin B12 products, with expectations for continued growth in the coming years.
The cyanocobalamin segment is expected to be the largest during the forecast period
The cyanocobalamin is expected to be the largest during the forecast period because cyanocobalamin is recognized as the most stable form of vitamin B12, which contributes to its dominant position in the market. Its stability allows for easier handling and longer shelf life compared to other forms of vitamin B12, such as methylcobalamin or adenosylcobalamin. This stability makes cyanocobalamin a preferred choice for manufacturers, as it can be produced, stored, and transported with less risk of degradation, thus ensuring consistent supply and availability
The dietary supplements segment is expected to have the highest CAGR during the forecast period
The dietary supplements segment is expected to have the highest CAGR during the forecast period owing to surge in demand for Vitamin B12 supplements due to their higher risk of deficiency. Technological advancements in supplement delivery, such as sublingual tablets, powders, and transdermal patches, have made it easier for consumers to incorporate Vitamin B12 into their daily routines.
North America is projected to hold the largest market share during the forecast period attributed to an increase in the use of dietary supplements, the advanced healthcare sector focusing on preventative care, and the availability of a wide range of products in the region. In addition, the growing prevalence of neural conditions and gastrointestinal issues is leading to an increased consumption of cobalamin supplements in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period owing to the high prevalence of diabetic neuropathy, growth in the geriatric population, and rising awareness regarding health supplements are the factors anticipated to drive the region's growth. Moreover, the presence of key players and their growing production capacities are poised to significantly contribute to the region's market growth over projected years.
Key players in the market
Some of the key players in Vitamin B12 market include BASF SE , Adisseo, BTSA Biotechnologias Aplicadas S.L., Chem Kart India Pvt Ltd, DSM, Farbest Brands, Lonza Group, Merck KGaA, NOW Foods, NutraGenesis LLC, Nutrilo GmbH, Pfizer Inc, Pharmavit GmbH, Rabar Pty Ltd, Rousselot, Spectrum Chemical Manufacturing Corp., SternVitamin GmbH & Co. K.G., Thermo Fisher Scientifica and Zhejiang Shengda Bio-Pharm Co., Ltd.
In July 2024, BASF has recently launched Haptex(R) 4.0, a next-generation polyurethane solution designed to revolutionize the production of sustainable synthetic leather. This innovative material is notable for being 100% recyclable, addressing long-standing challenges in the recycling of synthetic leather
In July 2024, Thermo Fisher Scientific has introduced a new pre-transplant risk assessment assay via its CLIA laboratory in Fishers, Ind., that helps assess risk of early acute rejection in kidney transplant recipients, providing data that may inform a more personalized approach to post-transplant immunosuppression management.
In June 2024, BASF and 'Pragati' extended full transparency & traceability to bio-based footwear solutions with SuCCESS code. It establishes a global standard for certifying castor oil and its derivatives, such as bio-based polyurethane, used in footwear manufacturing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.